These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17344344)

  • 1. Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay.
    Findlow J; Holland A; Martin D; Oster P; Balmer P; Borrow R
    Clin Vaccine Immunol; 2007 May; 14(5):556-61. PubMed ID: 17344344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assay.
    Findlow J; Holland A; Andrews N; Weynants V; Sotolongo F; Balmer P; Poolman J; Borrow R
    Clin Vaccine Immunol; 2007 Nov; 14(11):1451-7. PubMed ID: 17881507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
    Findlow J; Taylor S; Aase A; Horton R; Heyderman R; Southern J; Andrews N; Barchha R; Harrison E; Lowe A; Boxer E; Heaton C; Balmer P; Kaczmarski E; Oster P; Gorringe A; Borrow R; Miller E
    Infect Immun; 2006 Aug; 74(8):4557-65. PubMed ID: 16861642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.
    Partridge E; Lujan E; Giuntini S; Vu DM; Granoff DM
    Vaccine; 2017 Jul; 35(33):4236-4244. PubMed ID: 28651840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal surrogates of protection--serum bactericidal antibody activity.
    Borrow R; Balmer P; Miller E
    Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins.
    Hung MC; Humbert MV; Laver JR; Phillips R; Heckels JE; Christodoulides M
    Vaccine; 2015 Aug; 33(36):4486-94. PubMed ID: 26207592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding immunogenicity assessments for meningococcal serogroup B vaccines.
    Balmer P; Beeslaar J; Findlow J; Srivastava A
    Postgrad Med; 2020 Mar; 132(2):184-191. PubMed ID: 32124678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the bactericidal antibody against Neisseria meningitidis serogroup C strains after immunization with a divalent polysaccharide (A plus C) vaccine].
    Xu L; Luo LZ; Zhu BQ; He L; Gao Y; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):619-21. PubMed ID: 19957632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci.
    Harris SL; Tan C; Andrew L; Hao L; Liberator PA; Absalon J; Anderson AS; Jones TR
    Vaccine; 2018 Oct; 36(45):6867-6874. PubMed ID: 30269916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Michaelsen TE; Aase A; Käyhty H
    Infect Immun; 2005 Aug; 73(8):4694-703. PubMed ID: 16040982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody.
    Welsch JA; Granoff D
    Clin Vaccine Immunol; 2007 Dec; 14(12):1596-602. PubMed ID: 17913865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues surrounding standardization of meningococcal group W135 serology.
    Balmer P; Borrow R
    Vaccine; 2007 Sep; 25 Suppl 1():A63-8. PubMed ID: 17544550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
    Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
    Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison on the levels of human serum antibody against Neisseria meningitidis serogroup C measured using serum bactericidal assay and ELISA].
    Zhu BQ; Xu L; Zhou HJ; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):521-4. PubMed ID: 22883183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bactericidal antibody assays - The role of complement in infection and immunity.
    McIntosh ED; Bröker M; Wassil J; Welsch JA; Borrow R
    Vaccine; 2015 Aug; 33(36):4414-21. PubMed ID: 26187262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-component meningococcal serogroup B (MenB)-4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency.
    van den Broek B; van Els CACM; Kuipers B; van Aerde K; Henriet SS; de Groot R; de Jonge MI; Langereis JD; van der Flier M
    Clin Exp Immunol; 2019 Dec; 198(3):381-389. PubMed ID: 31487400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.
    Jordens JZ; Williams JN; Jones GR; Christodoulides M; Heckels JE
    Infect Immun; 2004 Nov; 72(11):6503-10. PubMed ID: 15501781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.